Pioneering the discovery and development of cortisol modulators.
201 - 500
π° $525.3k Post-IPO Equity on 2012-04
2 days ago
201 - 500
Director overseeing oncology corporate accounts. Focus on specialty distribution and patient access strategies.
πΊπΈ United States β Remote
π΅ $227k - $267.1k / year
π° $525.3k Post-IPO Equity on 2012-04
β° Full Time
π΄ Lead
π§βπΌ Account Executive
π½ H1B Visa Sponsor
2 days ago
201 - 500
Direct HCP marketing strategy and execution for Corcept's new oncology product launch in ovarian cancer.
πΊπΈ United States β Remote
π΅ $211.4k - $248.7k / year
π° $525.3k Post-IPO Equity on 2012-04
β° Full Time
π΄ Lead
π‘ Marketing
π½ H1B Visa Sponsor
October 5
201 - 500
Directs National/Regional Payer relationships to ensure profitable access for Corcept.
πΊπΈ United States β Remote
π΅ $227k - $267.1k / year
π° $525.3k Post-IPO Equity on 2012-04
β° Full Time
π΄ Lead
π§βπΌ Account Executive
π½ H1B Visa Sponsor
September 27
201 - 500
Lead oncology market launch as Regional Business Director at Corcept.
πΊπΈ United States β Remote
π΅ $235k - $274k / year
π° $525.3k Post-IPO Equity on 2012-04
β° Full Time
π΄ Lead
π Director
π½ H1B Visa Sponsor